Navigation Links
Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
Date:12/7/2008

SAN FRANCISCO, Dec. 7 /PRNewswire-USNewswire/ -- The largest study ever to examine the preventive use of blood-thinning medication to help prevent deadly blood clots in patients with cancer undergoing chemotherapy will be presented in a press conference on Sunday, December 7, at 9:30 a.m., during the 50th Annual Meeting of the American Society of Hematology in San Francisco, CA. Additional research being featured at the press conference includes studies that examine the use of three different investigational blood-thinning medications that belong to a new class of therapies called Factor Xa inhibitors. These studies evaluated the effectiveness of these medications in preventing blood clots: following major orthopedic surgery; in patients with atrial fibrillation; and in patients with deep-vein thrombosis.

Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Usually, the body naturally dissolves the clot when the injury has healed; however, when a clot does not dissolve naturally, it can become extremely dangerous. Deep-vein thrombosis, a type of blood clot that typically forms in a major vein of the leg, and pulmonary embolism, which occurs when a blood clot detaches from its point of origin and travels to the lungs where it becomes wedged and prevents adequate blood flow, are known collectively as venous thromboembolism.

"Venous thromboembolism is a serious public health problem that affects almost 1 million Americans each year and is responsible for more deaths each year than breast cancer, HIV disease, and motor vehicle crashes combined," said J. Evan Sadler, MD, moderator of the press conference and Professor of Medicine and of Biochemistry and Molecular Biophysics, Washington University Medical School, St. Louis, MO. "The hematology community is committed to continuously improving treatments for these patients, and the exciting research pr
'/>"/>

SOURCE American Society of Hematology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 Nektar ... International Inc. today announced positive results from its ... an investigational, extended half-life recombinant factor VIII (rFVIII) ... Factor (Recombinant)], which met its primary endpoint in ... arm compared to the on-demand arm. ...
(Date:8/21/2014)... , Aug. 21, 2014 The spinal column is ... human body. Signals carried to and from the brain through ... and nervous system. Injury or ailment here can be life ... a loss of control over their body. Though back injury ... person,s life, there are more options available to make things ...
(Date:8/21/2014)... 2014 /CNW/ - Eisai Limited is pleased to support the ... comic book available in Canada . The ... to educate children and their parents about epilepsy, the most ... more than 300,000 Canadians. Eisai is guided by a corporate ... which the patient is central – there was a need ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... 1 The ASCO Post captured initial ... that the breast cancer indication for bevacizumab (Avastin) be ... specialists, oncologists in private practice, third-party payers, and a ... ASCOPost.com and appear in the September issue of the ...
... Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS, ASX: UNS), ... received  510(k) market clearance from the U.S. Food and ... syringe is a variant of the Unitract™ 1mL Insulin ... year. Unlike insulin syringes which are primarily used by ...
Cached Medicine Technology:The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer 2The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer 3Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe 2Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe 3
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a ... years. He has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ... 2014. , GoDaddy is a popular supplier of cheap ... hosting solutions at affordable rates. It offers three Linux ... plans depend on the length of the contract. The ...
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... email marketing services that currently helps more than ... efforts has caught the attention of Shane Michaels, prompting ... still a crucial element for any online marketing campaign, ... replacing email in the marketing world,” reports Michaels. “AWeber ...
(Date:8/22/2014)... Buying a policy for different life insurance products can be ... types by insurers in the U.S. The Quotes Pros company ... public using its sortable tool at http://quotespros.com/life-insurance.html . ... expected to promote the discounts and special offerings for policies ... system is designed to help an adult locate a policy ...
(Date:8/22/2014)... Princeton, Indiana (PRWEB) August 22, 2014 ... because Toyota Indiana is on the grow ... add 300 jobs by summer 2016 to boost production ... expansion will bring Toyota Indiana’s overall investment to $4 ... in North America while providing additional flexibility to adjust ...
(Date:8/22/2014)... August 22, 2014 As the ... http://www.injurybeacon.com/power-morcellator/ ) in uterine surgeries continues to grow, ... companies have decided to limit coverage of uterine ... Telegram, Blue Cross-Blue Shield of Massachusetts will no ... involve morcellation as of September 1, 2014. Other ...
Breaking Medicine News(10 mins):Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 4
... 7 CardioFocus, Inc. ( www.cardiofocus.com ) ... allowing the company to commence European marketing of the ... fibrillation. The EAS is the latest generation, percutaneous ... patients with atrial fibrillation. This novel device incorporates ...
... ... , ... July 7, 2009 -- The Texas Hospital Association (THA) has joined ... members to hundreds of career Web sites., , , , ,"HEALTHeCAREERS is proud to ...
... ... (UCC) at the site of its medical office in Glendora, bringing more healthcare options to ... who have urgent but not life-threatening medical needs. , ... Glendora, CA (PRWEB) July 1, 2009-- HealthCare Partners recently opened a ...
... ... Users Location. , ... Plano, TX (PRWEB) July 7, 2009 -- Symon Communications, a global provider of in-venue ... iPhone application following a two week inaugural deployment supporting the Wimbledon tennis tournament in ...
... ... may be able to diagnose deep endometriosis and accurately locate lesions prior to surgery, according ... ... Using magnetic resonance imaging (MRI), radiologists may be able to diagnose deep endometriosis and accurately ...
... ... Web-based patient education service used by medical practices to deliver health information to patients ... ... 2009 -- Vivacare has recently enhanced its Web-based patient education service, providing ...
Cached Medicine News:Health News:CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter 2Health News:Texas Hospital Association Endorses HEALTHeCAREERS Network 2Health News:HealthCare Partners Opens Glendora Urgent Care Center 2Health News:HealthCare Partners Opens Glendora Urgent Care Center 3Health News:Symon Announces Revolutionary New Application InView Mobile™ 2Health News:Symon Announces Revolutionary New Application InView Mobile™ 3Health News:MRI Accurately Depicts Deep Endometriosis 2Health News:MRI Accurately Depicts Deep Endometriosis 3Health News:Vivacare Patient Education Service Enhancements Save Medical Practices Time and Money and Improve Patient Satisfaction 2Health News:Vivacare Patient Education Service Enhancements Save Medical Practices Time and Money and Improve Patient Satisfaction 3
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels - Ideal for use with CastAway System...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
... Tips offer a safe alternative to using ... for applications such as PCR(a), pipetting radioactive ... Tips are excellent for tissue culture, gel ... Tips prevent aerosol contaminants and liquids from ...
... The Rota-Filler 3000 combines a powerful motor ... adjustable pipet nozzle rotates to three positions ... convenience. Press the nozzle release button on ... the pivot nozzle position. The wide-angle position ...
Medicine Products: